56.23

1.31% 0.78

Bristol Myers Squibb Co (BMY)

Overview News Price History Option Chain Financials Why BMY Down? Discussions Forecast Stock Split Dividend History

Bristol Myers Squibb Co stock is traded at $56.23, with a volume of 3.88M. It is up +1.31% in the last 24 hours and up +4.10% over the past month. Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.

Previous Close:

$55.45

Open:

$55.14

24h Volume:

3.88M

Relative Volume:

0.38

Market Cap:

$112.31B

Revenue:

$47.44B

Net Income/Loss:

$-7.26B

P/E Ratio:

14.27

EPS:

3.94

Net Cash Flow:

$13.80B

1W Performance:

+7.00%

1M Performance:

+4.10%

6M Performance:

+27.70%

1Y Performance:

+6.35%

1-Day Range:

$54.72

$56.24

1-Week Range:

$52.29

$56.20

52-Week Range:

$39.35

$56.20

Bristol Myers Squibb Co Stock (BMY) Company Profile

Name

Bristol Myers Squibb Co

Sector

Healthcare (1181)

Industry

Drug Manufacturers - General (18)

Phone

(609) 252-4621

Address

ROUTE 206 AND PROVINCE LINE ROAD, PRINCETON, NY

Employee

34,100

Twitter

@BMSNEWS

Next Earnings Date

2024-10-31

Latest SEC Filings

BMY's Discussions on Twitter

Bristol Myers Squibb Co Stock (BMY) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-29-24	Downgrade	Barclays	Overweight → Equal Weight
Mar-11-24	Downgrade	Societe Generale	Buy → Hold
Feb-06-24	Downgrade	Redburn Atlantic	Buy → Neutral
Jan-03-24	Downgrade	BofA Securities	Buy → Neutral
Nov-15-23	Downgrade	Cantor Fitzgerald	Overweight → Neutral
Nov-09-23	Initiated	Deutsche Bank	Hold
Nov-02-23	Downgrade	Daiwa Securities	Outperform → Neutral
Oct-27-23	Downgrade	BMO Capital Markets	Outperform → Market Perform
Oct-27-23	Upgrade	HSBC Securities	Reduce → Hold
Oct-27-23	Downgrade	William Blair	Outperform → Mkt Perform
Oct-20-23	Resumed	UBS	Neutral
Jul-14-23	Initiated	HSBC Securities	Reduce
Jul-10-23	Initiated	SVB Securities	Market Perform
Jun-28-23	Initiated	Daiwa Securities	Outperform
Mar-06-23	Initiated	Jefferies	Hold
Jan-17-23	Initiated	Cantor Fitzgerald	Overweight
Nov-18-22	Initiated	Credit Suisse	Neutral
Oct-10-22	Downgrade	Guggenheim	Buy → Neutral
Sep-14-22	Downgrade	Berenberg	Buy → Hold
Jun-03-22	Downgrade	Raymond James	Outperform → Mkt Perform
Apr-06-22	Resumed	Morgan Stanley	Underweight
Dec-17-21	Initiated	Goldman	Buy
Dec-09-21	Resumed	Wells Fargo	Equal Weight
Nov-19-21	Initiated	BMO Capital Markets	Outperform
Nov-01-21	Downgrade	Argus	Buy → Hold
Jul-27-21	Resumed	Truist	Buy
Apr-30-21	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Apr-13-21	Upgrade	Truist	Hold → Buy
Nov-16-20	Upgrade	Societe Generale	Hold → Buy
Nov-10-20	Resumed	Bernstein	Mkt Perform
Nov-06-20	Downgrade	Gabelli & Co	Buy → Hold
Oct-19-20	Upgrade	Guggenheim	Neutral → Buy
Sep-29-20	Initiated	Berenberg	Buy
Jul-28-20	Initiated	Raymond James	Outperform
Apr-02-20	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Mar-23-20	Downgrade	Societe Generale	Buy → Hold
Feb-27-20	Initiated	Barclays	Equal Weight
Jan-06-20	Resumed	Citigroup	Buy
Dec-13-19	Upgrade	Argus	Hold → Buy
Nov-22-19	Resumed	Morgan Stanley	Equal-Weight
Oct-17-19	Resumed	BofA/Merrill	Buy
Aug-14-19	Upgrade	Atlantic Equities	Neutral → Overweight
May-28-19	Initiated	Goldman	Buy
May-20-19	Downgrade	Argus	Buy → Hold
May-03-19	Upgrade	Barclays	Equal Weight → Overweight
May-03-19	Resumed	JP Morgan	Overweight
Jan-15-19	Upgrade	Societe Generale	Sell → Buy
Oct-22-18	Downgrade	Citigroup	Buy → Neutral

View All

Bristol Myers Squibb Co Stock (BMY) Latest News

10:05 AM

Bristol-Myers Squibb's SWOT analysis: stock faces headwinds amid pipeline progress - Investing.com

10:05 AM

07:02 AM

Merck vs. Bristol-Myers: Analyst Views Differ After Q3 Earnings - MarketBeat

07:02 AM

Nov 04, 2024

Is Bristol-Myers Squibb Company (BMY) the Best Pharma Stock to Buy Right Now? - Insider Monkey

Nov 04, 2024

Leerink adjusts Bristol-Myers stock target upward on clinical progress, maintains Market Perform - Investing.com UK

Nov 04, 2024

Bristol-Myers Squibb Company (BMY) Stock Price, News, Quote & History - Yahoo Finance

Nov 04, 2024

Janney Montgomery Scott LLC Raises Holdings in Bristol-Myers Squibb (NYSE:BMY) - MarketBeat

Nov 04, 2024

Nov 03, 2024

Bristol Myers Screams To A Year-High After Walloping Profit Expectations - MSN

Nov 03, 2024

Nov 01, 2024

Bristol Myers Squibb Expects New Schizophrenia Treatment To Boost Long-Term Growth, Analysts Remain Cautious - Benzinga

Nov 01, 2024

Bristol-Myers Squibb Company (NYSE:BMY) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 01, 2024

BMS Delivers Q3 Beat, Raises 2024 Guidance Amid Strong Demand for Legacy and Newer Drugs - BioSpace

Nov 01, 2024

Bristol-Myers Squibb Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance

Nov 01, 2024